BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36591853)

  • 21. Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis.
    Sangiovanni A; Alimenti E; Gattai R; Filomia R; Parente E; Valenti L; Marzi L; Pellegatta G; Borgia G; Gambato M; Terreni N; Serio I; Belli L; Oliveri F; Maimone S; Brunacci M; D'Ambrosio R; Forzenigo LV; Russo FP; Rumi M; Barone M; Fracanzani AL; Raimondo G; Giannini EG; Brunetto MR; Villa E; Biganzoli E; Colombo M; Lampertico P
    J Hepatol; 2020 Sep; 73(3):593-602. PubMed ID: 32243959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Incidence of gastric cancer and risk factors in Suzhou cohort].
    Dai NB; Zhu XY; Jiang L; Gao Y; Hua YJ; Wang LC; Zhou JY; Wu M; Lu Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Apr; 43(4):452-459. PubMed ID: 35443297
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
    Cho HJ; Kim B; Lee JD; Kang DR; Kim JK; Lee JH; Shin SJ; Lee KM; Yoo BM; Lee KJ; Kim SS; Cheong JY; Cho SW
    Am J Gastroenterol; 2017 Mar; 112(3):460-470. PubMed ID: 27779194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.
    Xu XF; Xing H; Han J; Li ZL; Lau WY; Zhou YH; Gu WM; Wang H; Chen TH; Zeng YY; Li C; Wu MC; Shen F; Yang T
    JAMA Surg; 2019 Mar; 154(3):209-217. PubMed ID: 30422241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences.
    Evans AA; Chen G; Ross EA; Shen FM; Lin WY; London WT
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):369-76. PubMed ID: 11927497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
    Yang JD; Mohamed HA; Cvinar JL; Gores GJ; Roberts LR; Kim WR
    Am J Gastroenterol; 2016 Nov; 111(11):1573-1580. PubMed ID: 27527741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication.
    Huang CF; Yeh ML; Tsai PC; Hsieh MH; Yang HL; Hsieh MY; Yang JF; Lin ZY; Chen SC; Wang LY; Dai CY; Huang JF; Chuang WL; Yu ML
    J Hepatol; 2014 Jul; 61(1):67-74. PubMed ID: 24613362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis.
    Dong TS; Jacobs JP; Agopian V; Pisegna JR; Ayoub W; Durazo F; Enayati P; Sundaram V; Benhammou JN; Noureddin M; Choi G; Lagishetty V; Fiehn O; Goodman MT; Elashoff D; Hussain SK
    Dig Dis Sci; 2022 Aug; 67(8):3831-3841. PubMed ID: 34799768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoflavone consumption and subsequent risk of hepatocellular carcinoma in a population-based prospective cohort of Japanese men and women.
    Kurahashi N; Inoue M; Iwasaki M; Tanaka Y; Mizokami M; Tsugane S;
    Int J Cancer; 2009 Apr; 124(7):1644-9. PubMed ID: 19089922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance.
    Huang CF; Yeh ML; Huang CI; Lin YJ; Tsai PC; Lin ZY; Chan SY; Chen SC; Yang HI; Huang JF; Lu SN; Dai CY; Jen CL; Yuan Y; L'Italien G; Wang LY; Lee MH; Yu ML; Chuang WL; Chen CJ
    Oncotarget; 2017 Jul; 8(27):43925-43933. PubMed ID: 28159934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of bowel movement frequency and laxative use with risk of hepatocellular carcinoma in US women and men.
    Long L; Liu X; Jin L; Simon T; Ma W; Kim MN; Yang W; Meyerhardt JA; Chan AT; Giovannucci E; Zhang X
    Int J Cancer; 2021 Oct; 149(8):1529-1535. PubMed ID: 34028016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High Dietary Intake of Vegetable or Polyunsaturated Fats Is Associated With Reduced Risk of Hepatocellular Carcinoma.
    Yang W; Sui J; Ma Y; Simon TG; Petrick JL; Lai M; McGlynn KA; Campbell PT; Giovannucci EL; Chan AT; Zhang X
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2775-2783.e11. PubMed ID: 31927110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alcohol, postprandial plasma glucose, and prognosis of hepatocellular carcinoma.
    Abe H; Aida Y; Ishiguro H; Yoshizawa K; Miyazaki T; Itagaki M; Sutoh S; Aizawa Y
    World J Gastroenterol; 2013 Jan; 19(1):78-85. PubMed ID: 23326166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma.
    Sahasrabuddhe VV; Gunja MZ; Graubard BI; Trabert B; Schwartz LM; Park Y; Hollenbeck AR; Freedman ND; McGlynn KA
    J Natl Cancer Inst; 2012 Dec; 104(23):1808-14. PubMed ID: 23197492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project.
    Petrick JL; Campbell PT; Koshiol J; Thistle JE; Andreotti G; Beane-Freeman LE; Buring JE; Chan AT; Chong DQ; Doody MM; Gapstur SM; Gaziano JM; Giovannucci E; Graubard BI; Lee IM; Liao LM; Linet MS; Palmer JR; Poynter JN; Purdue MP; Robien K; Rosenberg L; Schairer C; Sesso HD; Sinha R; Stampfer MJ; Stefanick M; Wactawski-Wende J; Zhang X; Zeleniuch-Jacquotte A; Freedman ND; McGlynn KA
    Br J Cancer; 2018 Apr; 118(7):1005-1012. PubMed ID: 29520041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease.
    Lee TY; Wu JC; Yu SH; Lin JT; Wu MS; Wu CY
    Int J Cancer; 2017 Oct; 141(7):1307-1314. PubMed ID: 28509327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma.
    Rich NE; Murphy CC; Yopp AC; Tiro J; Marrero JA; Singal AG
    Aliment Pharmacol Ther; 2020 Aug; 52(4):701-709. PubMed ID: 32598091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Intake of Whole Grains and Dietary Fiber With Risk of Hepatocellular Carcinoma in US Adults.
    Yang W; Ma Y; Liu Y; Smith-Warner SA; Simon TG; Chong DQ; Qi Q; Meyerhardt JA; Giovannucci EL; Chan AT; Zhang X
    JAMA Oncol; 2019 Jun; 5(6):879-886. PubMed ID: 30789662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection.
    Lai MS; Hsieh MS; Chiu YH; Chen TH
    Hepatology; 2006 Jun; 43(6):1295-302. PubMed ID: 16729295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.